These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 7919825)

  • 41. Development of a Babesia rodhaini mouse assay for quality control of the serum component of a bovine babesiosis vaccine.
    Timms P; Rodwell BJ; Barry DN
    Res Vet Sci; 1983 Nov; 35(3):331-3. PubMed ID: 6665317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genotypic diversity in field isolates of Babesia bovis from cattle with babesiosis after vaccination.
    Lew AE; Bock RE; Croft JM; Minchin CM; Kingston TG; Dalgliesh RJ
    Aust Vet J; 1997 Aug; 75(8):575-8. PubMed ID: 9293339
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Babesia bovis and B. bigemina: Persistence of infection in friesian cows following vaccination with live antibabesial vaccines.
    Pipano E; Shkap V; Kriegel Y; Leibovitz B; Savitsky I; Fish L
    Vet J; 2002 Jul; 164(1):64-8. PubMed ID: 12359486
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of a frozen trivalent attenuated vaccine against Babesiosis and anaplasmosis in Brazil.
    Vidotto O; Barbosa CS; Andrade GM; Machado RZ; da Rocha MA; Silva SS
    Ann N Y Acad Sci; 1998 Jun; 849():420-3. PubMed ID: 9668502
    [No Abstract]   [Full Text] [Related]  

  • 45. Differential Bos taurus cattle response to Babesia bovis infection.
    Benavides MV; Sacco AM
    Vet Parasitol; 2007 Nov; 150(1-2):54-64. PubMed ID: 17919816
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of PCR assays to determine the genotype of Babesia bovis parasites isolated from cattle with clinical babesiosis soon after vaccination against tick fever.
    Bock RE; Lew AE; Minchin CM; Jeston PJ; Jorgensen WK
    Aust Vet J; 2000 Mar; 78(3):179-81. PubMed ID: 10860157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Babesia bigemina: attenuation of an Uzbek isolate for immunization of cattle with live calf- or culture-derived parasites.
    Shkap V; Rasulov I; Abdurasulov S; Fish L; Leibovitz B; Krigel Y; Molad T; Mazuz ML; Savitsky I
    Vet Parasitol; 2007 May; 146(3-4):221-6. PubMed ID: 17368728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Babesia bovis: analysis of and preliminary vaccination studies with a defined infected erythrocyte membrane binding antigen.
    Goodger BV; Waltisbuhl DJ; Wright IG; White M
    Int J Parasitol; 1992 Jul; 22(4):533-5. PubMed ID: 1644530
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunization of cattle with an inactivated polyvalent vaccine against anaplasmosis and babesiosis.
    Montenegro-James S; Toro M; Leon E; Guillen AT; Lopez R; Lopez W
    Ann N Y Acad Sci; 1992 Jun; 653():112-21. PubMed ID: 1626861
    [No Abstract]   [Full Text] [Related]  

  • 50. Identification of novel immune correlates of protection against acute bovine babesiosis by superinfecting cattle with
    Bastos RG; Laughery JM; Ozubek S; Alzan HF; Taus NS; Ueti MW; Suarez CE
    Front Immunol; 2022; 13():1045608. PubMed ID: 36466866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic diversity of Babesia bovis in virulent and attenuated strains.
    Mazuz ML; Molad T; Fish L; Leibovitz B; Wolkomirsky R; Fleiderovitz L; Shkap V
    Parasitology; 2012 Mar; 139(3):317-23. PubMed ID: 22075976
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of Babesia bovis 6cys A and 6cys B as components of transmission blocking vaccines for babesiosis.
    Alzan HF; Bastos RG; Ueti MW; Laughery JM; Rathinasamy VA; Cooke BM; Suarez CE
    Parasit Vectors; 2021 Apr; 14(1):210. PubMed ID: 33879245
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of diminazene block treatment on live redwater vaccine reactions.
    Combrink MP; Troskie PC
    Onderstepoort J Vet Res; 2004 Jun; 71(2):113-7. PubMed ID: 15373333
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaccines against bovine babesiosis--longest field trial?
    Angus BM
    Aust Vet J; 1999 Mar; 77(3):193. PubMed ID: 10197254
    [No Abstract]   [Full Text] [Related]  

  • 55. Evaluation of different heterologous prime-boost immunization strategies against Babesia bovis using viral vectored and protein-adjuvant vaccines based on a chimeric multi-antigen.
    Jaramillo Ortiz JM; Molinari MP; Gravisaco MJ; Paoletta MS; Montenegro VN; Wilkowsky SE
    Vaccine; 2016 Jul; 34(33):3913-9. PubMed ID: 27269058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Residual effect of antibabesial drugs on the live redwater blood vaccines.
    Combrink MP; Troskie PC; De Waal DT
    Ann N Y Acad Sci; 2002 Oct; 969():169-73. PubMed ID: 12381585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preliminary observations on the combined use of imidocarb and Babesia blood vaccine in cattle.
    Taylor RJ; McHardy N
    J S Afr Vet Assoc; 1979 Dec; 50(4):326-9. PubMed ID: 553972
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunization of cattle with a Babesia bigemina antigen in Freund's complete adjuvant.
    Kuttler KL; Johnson LW
    Am J Vet Res; 1980 Apr; 41(4):536-8. PubMed ID: 7406273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Growth of Babesia bovis parasites in stationary and suspension cultures and their use in experimental vaccination of cattle.
    Timms P; Stewart NP
    Res Vet Sci; 1989 Nov; 47(3):309-14. PubMed ID: 2595088
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of effective living vaccines against bovine babesiosis--the longest field trial?
    Callow LL; Dalgliesh RJ; de Vos AJ
    Int J Parasitol; 1997 Jul; 27(7):747-67. PubMed ID: 9279577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.